Insmed ENCORE Phase 3 Trial Hits Primary Endpoint; ARIKAYCE Drives Strong MAC Culture Conversion Gains

Insmed (NASDAQ:INSM) reported top-line results from its phase III ENCORE trial evaluating ARIKAYCE in adults with ...
Soy Carmín on MSN

Next full moon in 2026: exact date, meaning, and what it will bring to your life

Discover when the next full moon of 2026 will occur, its energetic meaning, and key predictions. Learn how it may influence ...
Healio

Novel anti-IgE antibody reduces chronic spontaneous urticaria disease activity

Adults with chronic spontaneous urticaria symptoms despite antihistamine use had reductions in disease activity with LP-003, a novel anti-IgE antibody, vs. placebo and omalizumab, according to phase 2 ...
Medscape

Can Exercise Ease ‘Chemobrain’ During Chemotherapy?

Engaging in a simple home-based exercise regimen of walking and resistance training during chemotherapy can help patients ...